92 related articles for article (PubMed ID: 20452869)
1. Rapid malignant transformation of low-grade astrocytomas: report of 2 cases and review of the literature.
Frazier JL; Johnson MW; Burger PC; Weingart JD; Quinones-Hinojosa A
World Neurosurg; 2010 Jan; 73(1):53-62; discussion e5. PubMed ID: 20452869
[TBL] [Abstract][Full Text] [Related]
2. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
3. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
4. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
[TBL] [Abstract][Full Text] [Related]
5. Long-term molecular changes in WHO grade II astrocytomas following radiotherapy.
Yue WY; Sai K; Wu QL; Xia YF; Yu SH; Chen ZP
Chin J Cancer; 2012 Mar; 31(3):159-65. PubMed ID: 22313596
[TBL] [Abstract][Full Text] [Related]
6. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
7. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas.
Parsa CF; Givrad S
Br J Ophthalmol; 2008 Jan; 92(1):40-6. PubMed ID: 17962395
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
11. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
[TBL] [Abstract][Full Text] [Related]
12. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of cerebral astrocytoma with 13N-ammonia.
Xiangsong Z; Changhong L; Weian C; Dong Z
J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
[TBL] [Abstract][Full Text] [Related]
15. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
17. Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma.
Hathout L; Pope WB; Lai A; Nghiemphu PL; Cloughesy TF; Ellingson BM
CNS Oncol; 2015; 4(4):247-56. PubMed ID: 26095141
[TBL] [Abstract][Full Text] [Related]
18. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
19. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
20. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
